BriaCell Therapeutics Corp. (BCT.TO) TSX
4.60
+0.04(+0.88%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.08M |
| Enterprise Value | -7.45M |
| P/E Ratio | -0.31 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.3 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.77 |
Fiscal Year
| Fiscal Year | July 31, 2025 |
| Most Recent Quarter | January 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.88 |
| Return On Equity | -1.66 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -107,930 |
| EBITDA | -27.43M |
| Net Income | -26.63M |
| Diluted EPS | -62.95 |
Balance Sheet
| Total Cash | 29.65M |
| Total Cash/Share | 10.58 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.19 |
| Book Value Per Share | 10.79 |
Price History
| 52-Week Change | -90.04 |
| 52-Week High | 49 |
| 52-Week Low | 4.13 |
| Moving Average 50 Days | 5.51 |
| Moving Average 200 Days | 9.7 |
Statistics
| Average Volume | 15,430 |
| Shares Outstanding | 1.88M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | August 25, 2025 |
